#HelmholtzDiabetes2025 The 12th Helmholtz Diabetes Conference has just started! 🚀 🌟Experts in #diabetes, #obesity & metabolic liver disease share their findings. Host: Prof. Stephan Herzig | Co-host: Prof. Anja Zeigerer 🎥 Why liver health matters in #DiabetesResearch! #MetabolicResearch

🎉🎬 @zeynepakata.bsky.social erhält den diesjährigen „ZukunftsWissen“-Preis von Leopoldina & Commerzbank-Stiftung. Die Informatikerin @tum.de und Helmholtz_Munich spricht über ihre Forschung zur erklärbaren #KI. Zum Video auf YouTube: www.youtube.com/watch?v=ZqIH...

🔬 Researchers led by Dr. Siegfried Ussar have identified insulin-like growth factor 2 (IGF2) as a central driver of fat tissue expansion during early postnatal development. 👉 Read more: t1p.de/71yka @diabresearch-dzd.bsky.social @genesdev.bsky.social #DiabetesResearch #IGF2

Oktoberfest Symposium 2025 – Advancing Type 1 Diabetes Research International experts in #type1diabetes are sharing the latest clinical insights & research findings: 👉Register now: t1p.de/mxt4n 📍 Conference Center, Campus #HelmholtzMunich 📅 Sept 30, 2025 @diabresearch-dzd.bsky.social @tum.de

🫁 #HelmholtzMunich and @parse.bsky.social are creating one of the largest #lung disease perturbation atlases. They will study lung cells to see how treatments affect them, guiding future #therapies & #AI models of lung biology. 👉 t1p.de/kj98f @fabiantheis.bsky.social @comphealthmunich.bsky.social

🫀 Researchers from #HelmholtzMunich, Roche Diagnostics, & TUM have created an integrated single-cell atlas of human atherosclerotic plaques, mapping immune & vascular cells and providing tools for research. 👉 Read more: t1p.de/fszz9 @tum.de

Imagine a Future Where Diseases Are Detected Before They Even Emerge  At #HelmholtzMunich, we work to make individual risks visible at an early stage – before disease develops.  👉 Discover more: t1p.de/6uxj7 @helmholtz.de #EarlyDetection #MedicineOfTheFuture #HealthResearch

🚀Prof. Niki Kilbertus, #HelmholtzMunich & @tum.de, receives ERC Starting Grant for DYNAMICAUS. His project merges #MachineLearning, causal inference & modeling to improve “if-then” reasoning in climate, health & epidemics. 👉 t1p.de/7c231 @erc.europa.eu @helmholtzai.bsky.social #ERCStG

Measuring Lung-Deposited Dose: A Step Toward Improved Therapies 🫁 A new comment by researchers at #HelmholtzMunich shows why measuring the lung-deposited dose is key for safer, more effective therapies. 👉 t1p.de/c9svi

New #Grant Supports #Fr1da Study on Early T1D Screening Breakthrough T1D supports the Fr1da-Cohort-Study from #HelmholtzMunich with a grant to strengthen early-stage #Type1Diabetes screening & care for children and families. 👉 t1p.de/i2z3c @bvkj.bsky.social

Using AI and DNA Signals to Detect Living Microbes 🔬 #HelmholtzMunich & @helmholtzai.bsky.social show #AI can infer microbial viability from raw nanopore signals – distinguishing live vs. dead microbes for more precise genomic diagnostics in health & environmental monitoring. 👉 t1p.de/t692x

New Collaboration – Advancing Drug Discovery for Pulmonary Fibrosis 🫁 #HelmholtzMunich & Boehringer Ingelheim join forces to find new treatment options for #PulmonaryFibrosis using single-cell genomics & #AI. 👉 t1p.de/qhm8a @boehringerglobal.bsky.social @fabiantheis.bsky.social #AIinMedicine

📣Sign up for the Bavarian Conference on AI in Medicine at the #BAdW! #HelmholtzMunich co-organizes the conference uniting #AI experts & beginners to discuss advances in AI-driven medical research. 👉 Register & submit your abstract: t1p.de/8fuuw 🔽Read more in the comments.🔽

🎧#Podcast with Prof. Vasilis Ntziachristos about Photoacoustic Imaging: 👉https://t1p.de/o4n9t Learn more about groundbreaking medical imaging tools in the #HelmholtzMunich Highlight: "The Light that Listens to Health and Disease" 👉https://t1p.de/szrqp @munichimaging.bsky.social

Zooming in Reveals How Our Cells Work Inside Prof. Fabian Theis, #HelmholtzMunich, together with international partners, has helped to understand better how stem cells develop into blood cells. 👉 t1p.de/i34dh @fabiantheis.bsky.social #genomics #health #proteomics #bloodcells

CarePath: #HelmholtzMunich Joins EU Project The #CarePath initiative supports people with chronic conditions like #type2diabetes & #obesity through personalized tools to improve treatment adherence & wellbeing. #HelmholtzMunich is a central research partner in the five-year project: t1p.de/2ldqz

#HelmholtzMunich’s BNMRZ has joined Germany’s Instruct-ERIC Centre 🔬 Instruct-ERIC provides open access to advanced structural biology technologies. #BNMRZ advances innovation in #NMR methods, drug discovery, and imaging - boosting the German Centre’s capabilities. 👉 Read more: t1p.de/pjtyv

From Lab to Launch 🚀 #HelmholtzMunich joins Deep Science Ventures & SPRIND to support the Venture Science Doctorate – a new PhD program merging #science & #entrepreneurship. 👉 Read more: t1p.de/z4r0y 👉 Apply now: t1p.de/hpm7r @sprind-en.bsky.social @helmholtz.de #PhD2026 #VentureScienceDoctorate

🔬 New dual-imaging technology - #O2E - by #HelmholtzMunich, @tum.de ‬& @meduniwien.ac.at enables earlier detection of esophageal #cancer.‬‬‬ 👉 Read more in our news: t1p.de/qb9jh 🔗 To the original publication: t1p.de/ftgim @munichimaging.bsky.social

🔬 New study by #HelmholtzMunich, #DZD & Goethe University Frankfurt shows vidofludimus calcium may delay #Type1Diabetes by rebalancing immune cells. 👉 Read more: t1p.de/n6s0g @daniellab.bsky.social @diabresearch-dzd.bsky.social @goetheuni.bsky.social

Prof. Carsten Marr has assumed the W3 Professorship for AI in Cell Therapy & Hematology at LMU University Hospital. Marr also directs the Institute of AI for Health at #HelmholtzMunich. 🔬His #AI work advances diagnosis & treatment of blood diseases. 👉 Read more: t1p.de/enty6

Fighting #HepatitisB #TherVacB, a new therapeutic vaccine for chronic hepatitis B from #HelmholtzMunich, starts phase 1b/2a trial in patients. It aims to boost the immune system to eliminate the virus. 👉 t1p.de/qcncm @lmu-klinikum.bsky.social @tum.de @ulrike-protzer.bsky.social

🌱 When Roots Warn Shoots: Discovery Sheds Light on Plant-Wide Immunity Researchers at #HelmholtzMunich found that N-hydroxypipecolic acid (NHP) acts as a root-to-shoot signal, linking soil microbes to whole-plant defense – a key step for resilient, productive crops. 👉Read more: t1p.de/rguhm

🔬 New study: The #liver plays an active role in cancer #cachexia via silenced clock gene REV-ERBα. Key step toward new therapies. 👉 Read more: t1p.de/eh136 @tum.de @diabresearch-dzd.bsky.social @dorie00.bsky.social ky.social #CancerResearch #Cachexia #Liver

Good mood & fast legs at #B2Run2025 🏃‍♀️🏃‍♂️ Over 90 colleagues from #HelmholtzMunich ran through Olympiapark – under the motto "Research is a marathon, not a sprint”. Big thanks to all supporters & to Stiftung AtemWeg for the shirts! #CorporateHealth

📢 Advance Your Career: Apply by July 31 to speak at the #TalentForum at #HelmholtzMunich! #PostDoc aiming for a group leader role? Present your work in #Epigenetics & Nucleic Acids Research and connect with leaders in the field. 🗓️ Nov 18–19, 2025, Munich ⏳Deadline: July 31, 2025 👉 t1p.de/n2n2r

🌍 A new commentary in Lancet examines how environmental changes - climate change, pollution, biodiversity loss - are affecting human health. It outlines four action areas and marks 10 years since #PlanetaryHealth was introduced. 👉 t1p.de/d6o50 @traidlhoffmann.bsky.social @jhu.edu

Three #ERC Proof of Concept Grants for #HelmholtzMunich 🚀 Projects by Marcus Conrad, Fabian Theis & André C. Stiel target cancer, AI-guided drug delivery & chip-based diagnostics. 👉 t1p.de/hz9x3 @erc.europa.eu @fabiantheis.bsky.social

Label-Free Cancer Monitoring – Imaging Technology Tracks Therapy Response in Real Time The new mid-infrared optoacoustic microscopy technology tracks cancer treatment response in individual cells – without dyes or labels. 👉 t1p.de/6h6f7 @tum.de @munichimaging.bsky.social #Myeloma

🏆 Prof. Magdalena Götz, #HelmholtzMunich, wins the 2025 #FutureInsightPrize for pioneering work in brain regeneration - reprogramming glial cells into neurons opens new hope for treating Alzheimer’s & Parkinson’s. 👉 t1p.de/f06kg @lmumuenchen.bsky.social @merckgroup.bsky.social

Congrats to Helen Charles for winning the Poster Prize at #DZL Annual Meeting👏 Helen Charles from #HelmholtzMunich, was awarded for the poster on the publication: “Type-3 cytokines induce Polarization of Airway Epithelial Cells toward a Novel Mucosal E3 Phenotype”. @tum.de #PosterPrize

Same Workout, Different Results? 💡 A new study by #HelmholtzMunich, the University Hospital Tübingen, and DZD presents the first comprehensive molecular analysis of sex-specific differences in skeletal muscle metabolism. 👉 t1p.de/847j5 @diabresearch-dzd.bsky.social #Type2Diabetes

The Göttingen Academy of Sciences and Humanities honors Prof. Matthias Tschöp for his pioneering research in metabolic medicine with the Lichtenberg Medal.🎉 👉 t1p.de/hbq22 @tum.de 📸©Adrienne Lochte #LichtenbergMedal #DiabetesResearch #Metabolism #Obesity #Prevention

Soapbox Science Munich 2025 Curious about science that’s easy to understand? 👉 t1p.de/oo82j Four speakers from #HelmholtzMunich will take part – sharing their research while standing on a soapbox! 🗓️ 5th July 2025, 2pm – 5pm   📍 Rindermarkt, Munich No registration! @munichsoapbox.bsky.social

🏆Awards at #Helmholtz Munich: Florencia Merino, Ruyu Ma, and Dr. Otmar Schmid were honored for excellent research & committed supervision. 👉 t1p.de/5y493 #PhDlife #EarlyCareerResearchers

🏆 Helmholtz Munich wins the #m4Award2025 for SYNTRA, an #AI-powered #RNA delivery project. The pre-seed prize supports spin-offs in Bavaria. SYNTRA aims to safely deliver RNA to target cells, enabling new therapies for genetic & other diseases. 👉 t1p.de/6fyup @fabiantheis.bsky.social #BioM

Centaur – An AI That Thinks Like Us🧠 Researchers at #HelmholtzMunich have developed an #AI model that simulates human decision-making with remarkable precision. 👉 t1p.de/4kjoy @marcelbinz.bsky.social ‬ #AI #HumanCenteredAI #Psychology #MentalHealth

Cracking Cell Complexity Together 💡 #OpenProblems is an open-source platform co-led by #HelmholtzMunich and Yale to benchmark and improve computational tools for single-cell genomics. It offers standardized benchmarking, transparent evaluations, and cloud-based workflows.

💉 #HelmholtzMunich joins the European Vaccines Hub (EVH) to boost #PandemicPreparedness. 🔬 The EVH unites EU partners – covering the full pipeline from #vaccine discovery to manufacturing. 👉 t1p.de/vdi16 @ec.europa.eu @evhproject.bsky.social

Ferroptosis Identified as Key Driver in Prion Disease Neurodegeneration🧠 👉 t1p.de/3uhhr A study led by Dr. Joel Schick, #HelmholtzMunich, and Dr. Cathryn Haigh (#NIH), links #ferroptosis to brain damage in #PrionDiseases such as Creutzfeldt-Jakob Disease. @dfg.de @natureportfolio.nature.com

Congratulations to Prof. Zeynep Akata on receiving the 2025 ZukunftsWissen Award from the German National Academy of Sciences Leopoldina and the Commerzbank Foundation. 👉 t1p.de/kdajf The prize will be awarded in September at the #Leopoldina Assembly. @zeynepakata.bsky.social @leopoldina.org

Air Pollution and the Sense of Smell A new KORA FIT study by #HelmholtzMunich & partners shows that long-term exposure to traffic-related air pollution is linked to an impaired sense of smell – a potential early sign of neurodegenerative changes. 👉 t1p.de/gs1gs #AirPollution

Join the Talent Forum at #HelmholtzMunich Inspiring talks by international junior group leaders at the forefront of cutting-edge research in Epigenetics & Nucleic Acids Research: 👉 t1p.de/n2n2r 🗓️18–19 Nov 2025 @epihmgu.bsky.social @metorrespadilla.bsky.social #epigenetics #TalentForum

Congratulations: to Antje Körner, #HelmholtzMunich, on receiving the 2025 Leipzig Science Award! 👏 🏆 The prize recognizes her research on childhood #obesity and metabolic diseases. 👉 t1p.de/m8bdf unileipzig.bsky.social‬#ChildhoodObesityt#LeipzigScienceAwardrd

🏅 Prof. Carsten Schmidt-Weber, #HelmholtzMunich, received the EAACI Clinical Fellow Award 2025 for outstanding work in #allergy & clinical immunology. 🔬His research focuses on allergic inflammation & early therapies for childhood asthma. 👉 t1p.de/g7s1x #EAACI2025 #AllergyResearch

30 Jahre Helmholtz-Gemeinschaft🎉 Als Teil der #HelmholtzGemeinschaft treibt #HelmholtzMunich Innovationen in der Gesundheitsforschung voran! Feiere mit uns & verfolge das spannende Programm im #Livestream: 👉 t1p.de/e8rum 📅 24.6.2025, 18:00 @helmholtz.de #Helmholtz30

Study finds shared biological pathways in depression, bipolar & schizophrenia. 🧠 Exon-level analysis shows disruptions in circadian rhythm, cortisol & dopamine signaling. 🌟Toward biology-based diagnosis & treatment. 🔗Read more: t1p.de/htnh0 @mpi-psychiatry.bsky.social @sydney.edu.au

🤝 #HelmholtzMunich & Northwestern University - The Feinberg School of Medicine team up to advance #AIforHealth! Research stays are underway to drive innovation & support early career scientists. 🔗 t1p.de/19f6k @ewaszczurek.bsky.social @fabiantheis.bsky.social #AIforHealth #EarlyCareerScientists

🧠 New insights into how genes influence brain shape - not just size. 80 genetic variants linked to brain structure and health risks like neurodegeneration. 👉More here: t1p.de/1ykzg @fz-juelich.de @hhu.de

Cancer Plasticity Atlas To Improve Cancer Therapies #HelmholtzMunich joins @sangerinstitute.bsky.social & @parse.bsky.social to build the Cancer Plasticity Atlas, using #AI & single-cell data to model therapy response. 👉 t1p.de/13ifi @fabiantheis.bsky.social @mgarnett.bsky.social #CancerResearch